Skip to main content
. 2018 Mar 22;23(1):43–50. doi: 10.6065/apem.2018.23.1.43

Table 2.

Number of registered patients from 2012 to 2016

Year No. of registered patients/yr Accumulated No. of patients
2012 717 717
2013 579 1,296
2014 247 1,543
2015 343 1,886
2016 310 2,196

The numbers in the left column are the number of registered patients in each year whereas those in the right column are the cumulative number of patients at the end of each year. Since the initiation of LG Growth Study (LGS) registry on 9 November 2011, patients in need of recombinant human growth hormone have been continually registered in the LGS registry.